Table 9.
Subjects in Model | Gene-Gene Interaction | ||
---|---|---|---|
GH1 | IGF1 | GH1*IGF1 | |
Triads | −0.14 (−0.76–0.47, 0.64) | −0.46 (−1.09–0.18, 0.16) | 0.22 (−0.34–0.77, 0.44) |
Triads & Dyads | −0.10 (−0.60–0.40, 0.70) | −0.30 (−0.80–0.20, 0.24) | 0.24 (−0.21–0.69, 0.30) |
Cases & Controls | −0.01 (−0.32–0.31, 0.98) | 0.06 (−0.28–0.40, 0.74) | −0.13 (−0.46–0.21,0.46) |
Triads & Controls | −0.05 (−0.36–0.27, 0.76) | −0.07 (−0.41–0.27, 0.69) | −0.03 (−0.36–0.29, 0.84) |
Triads, Dyads & Controls | −0.05 (−0.36–0.26, 0.75) | −0.07 (−0.41–0.26, 0.67) | 0.01 (−0.32–0.34, 0.95) |
IGFBP3 | IGF1 | IGFBP3*IGF1 | |
Triads | 0.70 (0.14–1.26, 0.01) | 0.19 (−0.59–0.98, 0.63) | −0.33 (−0.89–0.23, 0.25) |
Triads & Dyads | 0.41 (−0.05–0.87, 0.09) | 0.08 (−0.58–0.74, 0.81) | −0.09(−0.53–0.35, 0.67) |
Cases & Controls | 0.14 (−0.18–0.45, 0.39) | 0.06 (−0.36–0.47, 0.78) | −0.09 (−0.40–0.24, 0.58) |
Triads, Cases & Controls | 0.27 (−0.04–0.57, 0.09) | 0.10 (−0.29–0.50, 0.61) | −0.16 (−0.47–0.16, 0.32) |
Triads, Dyads, Cases & Controls | 0.22 (−0.09–0.52, 0.16) | 0.07 (−0.34–0.48, 0.73) | −0.09 (−0.40–0.22, 0.55) |